Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas

Endocrine

Volumn 20, Issue 3, 2003, Pages 279-283

  Colao, Annamaria ^a   Filippella, Mariagiovanna ^a   Di Somma, Carolina ^a   Manzi, Simona ^a   Rota, Francesca ^a   Pivonello, Rosario ^a   Gaccione, Maria ^a   De Rosa, Michele ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Lanreotide; Octreotide; Pituitary adenomas; Somatostatin

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FOLLITROPIN; GROWTH HORMONE; IODINE 123; LIOTHYRONINE; LUTEINIZING HORMONE; METHOXYBENZAMIDE IODINE I 123; OCTREOTIDE; OCTREOTIDE LAR; PASIREOTIDE; PENTETATE INDIUM IN 111; PENTETREOTIDE IN 111; PROLACTIN; RECEPTOR SUBTYPE; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN 2 RECEPTOR; SOMATOSTATIN 5 RECEPTOR; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

CANCER RADIOTHERAPY; CLINICAL TRIAL; CONVALESCENCE; DRUG CHOICE; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG UTILIZATION; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; LIOTHYRONINE BLOOD LEVEL; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; SLOW RELEASE FORMULATION; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL; TRANSSPHENOIDAL SURGERY; TUMOR VOLUME; VISUAL FIELD;

EID: 0037726793     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:20:3:279     Document Type: Review

References (48)

1. Guillemin, R. (1978). Science 202, 390-402.
2. Guillemin, R. (1981). J. Endocrinol. 90, 3-10.
3. Lamberts, S. W., Krenning, E. P., and Reubi, J. C. (1991). Endocr. Rev. 12, 450-482.
4. Newman, C. B., Melmed, S., George, A., et al. (1998). J. Clin. Endocrinol. Metab. 83, 3034-3040.
5. Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., and Hofland, L. J. (1996). N. Engl. J. Med. 334, 246-254.
6. Morange I, de Boisvilliers F, Chanson P, et al. (1994). J. Clin. Endocrinol. Metab. 79, 145-151.
7. Giusti, M., Gussoni, G., Cuttica, C. M., Giordano, G., and the Italian Multicenter Slow Release Lanreotide Study Group. (1996). J. Clin. Endocrinol. Metab. 81, 2089-2097.
8. Gillis, J. C., Noble, S., and Goa, K. L. (1997). Drugs 53, 681-699.
9. Colao, A., Ferone, D., Marzullo, P., et al. (2001). J. Clin. Endocrinol. Metab. 86, 2779-2786.
10. Beck-Peccoz, P., Brucker-Davis, F., Persani, L., Smallridge, R. C., and Weintraub, B. D. (1996). Endocr. Rev. 17, 610-638.
11. Brucker-Davis Oldfield, E. H., Skarulis, M. C., Doppman, J. L., and Weintraub, B. D. (1999). J. Clin. Endocrinol. Metab. 84, 476-486.
12. Freda, P. U. and Wardlaw, S. L. (1999). J. Clin. Endocrinol. Metab. 84, 3859-3866.
13. Bevan, J. S., Webster, J., Burke, C. W., and Scanlon, M. F. (1992). Endocr. Rev. 13, 221-235.
14. Bertherat, J., Brue, T., Enjalbert, A., et al. (1992). J. Clin. Endocrinol. Metab. 75, 540-546.
15. Losa, M., Magnani, P., Mortini, P., et al. (1997). Eur. J. Nucl. Med. 24, 728-731.
16. Comi, R. J., Gesunheit, N., Murray, L., Gorden, P., and Weintraub, B. D. (1987). N. Engl. J. Med. 317, 12-17.
17. Chanson, P., Weintraub, B. D., and Harris, A. G. (1993). Ann. Intern. Med. 119, 236-240.
18. Fukuda, T., Yokoyama, N., Tamai, M., et al. (1998). Intern. Med. 37, 1027-1030.
19. Gancel, A., Vuillermet, P., Legrand, A., Catus, F., Thomas, F., and Kuhn, J. M. (1994). Clin. Endocrinol. 40, 421-428.
20. Kuhn, J. M., Arlot, S., Lefebvre, H., et al. (2000). J. Clin. Endocrinol. Metab. 85, 1487-1491.
21. Caron, P., Arlot, S., Bauters, C., et al. (2001). J. Clin. Endocrinol. Metab. 86, 2849-2853.
22. Katnelson, L., Alexander, J. M., and Klibanski, A. (1993). J. Clin. Endocrinol. Metab. 76, 1089-1094.
23. Ebersold, M. J., Quast, L. M., Laws, E. R., Scheitauer, B., and Randall, R. V. (1986). J. Neurosurg. 64, 713-719.
24. Harris, P. E., Afshar, F., Coates, P., et al. (1989). Q. J. Med. 71, 417-427.
25. Colao, A., Cerbone, G., Cappabianca, P., et al. (1998). J. Endocrinol. Invest. 21, 284-290.
26. Littley, M. D., Shalet, S. M., Beardwell, C. G., Ahmed, S. R., Applegate, G., and Sutton, M. I. (1989). Q. J. Med. N. Series 70, 145.
27. Turner, H. E., Stratton, I. M., Byrne, J. V., Adams, C. B., and Wass, J. A. (1999). Clin. Endocrinol. 51, 281-284.
28. Lamberts, S. W. J., de Herder, W. W., van der Lely, A. J., and Hofland, L. J. (1995). Endocrinologist 5, 448-451.
29. Ferone, D., Lastoria, S., Colao, A., et al. (1998). J. Clin. Endocrinol. Metab. 83, 248-252.
30. Colao, A., Ferone, D., Lastoria, S., et al. (2000). Clin. Endocrinol. 52, 437-445.
31. Faglia, G., Bazzoni, N., Spada, A., et al. (1991). J. Clin. Endocrinol. Metab. 73, 850-856.
32. Plockinger, U., Reichel, M., Fett, U., Saeger, W., and Quabbe, H. J. (1994). J. Clin. Endocrinol. Metab. 79, 1416-1423.
33. Duet, M., Mundler, O., Ajzenberg, C., et al. (1994). Eur. J. Nucl. Med. 21, 647-650.
34. Florio, T., Thellung, S., Arena, S., et al. (1999). Eur. J. Endocrinol. 141, 396-408.
35. Colao, A., Lastoria, S., Ferone, D., et al. (1999). J. Endocrinol. Invest. 22, 176-183.
36. Warnet, A., Harris, A. G., Renard, E., Martin, D., James-Deidier, A., Chaumet-Riffaud, P., and the French multicenter octreotide study group. (1997). Neurosurgery 41, 786-797.
37. De Bruin, T. W. A., Kwekkeboom, D. J., van't Verlaat, J. W., et al. (1992). J. Clin. Endocrinol. Metab. 75, 1310-1317.
38. van Hagen, P. M., Baarsma, G. S., Mooy, C. M., et al. (2000). Eur. J. Endocrinol. 143(Suppl. 1), S43-S51.
39. Wagenaar, A. H., Harris, A. G., van der Lely, A. J., and Lamberts, S. W. (1991). Acta Endocrinol. (Copenh.) 125, 637-642.
40. Flogstad, A. K., Halse, J., Grass, P., et al. (1994). J. Clin. Endocrinol. Metab. 79, 461-465.
41. Lombardi, G., Colao, A., Ferone, D., et al. (1995). Eur. J. Endocrinol. 132, 559-564.
42. Marzullo, P., Ferone, D., Di Somma, C., et al. (1999). Pituitary 1, 115-120.
43. Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., and Patel, Y. C. (2000). Science 288, 154-157.
44. Andersen, M., Bjerret, P., Schroder, H. D., et al. (2001). Clin. Endocrinol. 54, 23-30.
45. Jaquet, P., Ouafik, L., Saveanu, A., et al. (1999). J. Clin. Endocrinol. Metab. 84, 3268-3276.
46. Shimon, I., Yan, X., Taylor, J. E., Weiss, M. H., Culler, M. D., and Melmed, S. (1997). J. Clin. Invest. 100, 2386-2392.
47. Culler, M. D., Taylor, J. E., and Moreau, J. P. (2002). Ann. Endocrinol. (Paris) 63, 2S5-12.
48. Weckbecker, G., Briner, U., Lewis, I., and Bruns, C. (2002). Endocrinology 143, 4123-4130.